CEROW

CERo Therapeutics Holdings, Inc.

Price Chart

Latest Quote

$0.00

+0.00 (+146.15%)

Current Price

Previous Close	$0.00
Open	$0.00
Day High	$0.00
Day Low	$0.00
Volume	50,000

Fetched: 2026-06-17T18:04:45

Stock Information

Total Debt	$598K
Cash Equivalents	$857K
Net Income	$-95.96M
Exchange	NGM

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Income	$-95.96M
Book/sh	$-0.46
Employees	8

Financial Ratios

Quick Ratio	0.08
Current Ratio	0.14

Returns & Margins

ROA

-241.15%

Ownership

Insider & Institutional transactions data not available

Valuation Ratios

P/B

-0.01

Analyst Data

Recommendation

none

Technical Indicators

Shares Float

43.14M

Performance History

YTD

+0.00%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-17	$0.00	50,000

About CERo Therapeutics Holdings, Inc.

CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company's lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.

📰 Latest News

Sector Update: Health Care Stocks Retreat Late Afternoon

MT Newswires • 2025-06-17T19:53:56Z

Period:

Income Statement (Annual)

Metric	2023-12-31	2022-12-31	2021-12-31
Revenue
Total Revenue	$0	$0	$0
Operating Revenue	$0	$0	$0
Expenses
Total Expenses	$7,675,049	$11,971,231	$11,616,331
Other Income Expense	$247,132	-	-
Other Non Operating Income Expenses	$-62,182	-	-
Net Non Operating Interest Income Expense	$138,340	$142,115	$986,711
Operating Expense	$7,675,049	$11,971,231	$11,616,331
General And Administrative Expense	$2,386,469	$2,125,628	$2,479,447
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-7,289,577	$-11,829,116	$-10,629,620
Net Interest Income	$138,340	$142,115	$986,711
Interest Income	$138,340	$142,115	$986,711
Normalized Income	$-7,598,891	$-11,829,116	$-10,629,620
Net Income From Continuing And Discontinued Operation	$-7,289,577	$-11,829,116	$-10,629,620
Total Operating Income As Reported	$-7,675,049	$-11,971,231	$-11,616,331
Net Income Common Stockholders	$-7,289,577	$-11,829,116	$-10,629,620
Net Income	$-7,289,577	$-11,829,116	$-10,629,620
Net Income Including Noncontrolling Interests	$-7,289,577	$-11,829,116	$-10,629,620
Net Income Continuous Operations	$-7,289,577	$-11,829,116	$-10,629,620
Pretax Income	$-7,289,577	$-11,829,116	$-10,629,620
Special Income Charges	$8,144	-	-
Interest Income Non Operating	$138,340	$142,115	$986,711
Operating Income	$-7,675,049	$-11,971,231	$-11,616,331
Other
Tax Effect Of Unusual Items	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-6,867,165	$-10,898,422	$-10,880,858
Total Unusual Items	$309,314	-	-
Total Unusual Items Excluding Goodwill	$309,314	-	-
Reconciled Depreciation	$1,117,198	$1,072,809	$735,473
EBITDA (Bullshit earnings)	$-6,557,851	$-10,898,422	$-10,880,858
EBIT	$-7,675,049	$-11,971,231	$-11,616,331
Diluted NI Availto Com Stockholders	$-7,289,577	$-11,829,116	$-10,629,620
Otherunder Preferred Stock Dividend	$0	-	-
Other Special Charges	$-8,144	-	-
Gain On Sale Of Security	$301,170	-	-
Research And Development	$5,288,580	$9,845,603	$9,136,884
Selling General And Administration	$2,386,469	$2,125,628	$2,479,447
Other Gand A	$2,386,469	$2,125,628	$2,479,447

Fetched: 2026-02-02

Balance Sheet (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Net Tangible Assets	$-1,894,563	$-42,057,695	$-34,870,780	$-23,428,359
Total Assets	$6,206,929	$5,126,302	$11,349,488	$24,175,570
Total Non Current Assets	$2,492,888	$3,156,267	$4,273,465	$4,652,043
Non Current Deferred Assets	$500,000	$0	-	-
Current Assets	$3,714,041	$1,970,035	$7,076,023	$19,523,528
Other Current Assets	$274,749	$368,780	$256,459	$306,046
Current Deferred Assets	$112,232	$0	-	-
Cash Cash Equivalents And Short Term Investments	$3,327,060	$1,601,255	$6,819,564	$19,217,482
Cash And Cash Equivalents	$3,327,060	$1,601,255	$6,819,564	$19,217,482
Cash Financial	$3,327,060	$1,601,255	$6,819,564	$19,217,482
Debt
Total Debt	$1,575,499	$2,944,283	$3,016,964	$3,602,214
Long Term Debt And Capital Lease Obligation	$699,107	$1,575,499	$2,344,590	$3,016,964
Current Debt And Capital Lease Obligation	$876,392	$1,368,784	$672,374	$585,250
Current Debt	-	$599,692	-	-
Liabilities
Total Liabilities Net Minority Interest	$8,101,492	$47,183,997	$46,220,268	$47,603,929
Total Non Current Liabilities Net Minority Interest	$699,107	$43,676,843	$45,056,315	$45,765,681
Current Liabilities	$7,402,385	$3,507,154	$1,163,953	$1,838,248
Other Current Liabilities	$20,000	$321,992	-	-
Current Notes Payable	$0	$599,692	-	-
Payables And Accrued Expenses	$6,261,691	$1,747,681	$471,821	$488,695
Interest Payable	$0	$27,637	-	-
Payables	$4,671,266	$1,671,745	$391,185	$459,919
Dividends Payable	$85,500	$0	-	-
Total Tax Payable	$78,448	$0	-	-
Accounts Payable	$4,507,318	$1,671,745	$391,185	$459,919
Derivative Product Liabilities	-	-	$610,381	$647,373
Equity
Common Stock Equity	$-5,071,009	$-42,057,695	$-34,870,780	$-23,428,359
Preferred Stock Equity	$3,176,446	-	-	-
Total Equity Gross Minority Interest	$-1,894,563	$-42,057,695	$-34,870,780	$-23,428,359
Stockholders Equity	$-1,894,563	$-42,057,695	$-34,870,780	$-23,428,359
Other Equity Interest	$-1,295,444	-	-	-
Retained Earnings	$-70,917,853	$-43,089,821	$-35,800,244	$-23,971,128
Preferred Securities Outside Stock Equity	$0	$42,101,344	$42,101,344	$42,101,344
Other
Ordinary Shares Number	$137,940	$5,964	$5,146	$5,146
Share Issued	$137,940	$5,964	$5,146	$5,146
Tangible Book Value	$-5,071,009	$-42,057,695	$-34,870,780	$-23,428,359
Invested Capital	$-5,071,009	$-41,458,003	$-34,870,780	$-23,428,359
Working Capital	$-3,688,344	$-1,537,119	$5,912,070	$17,685,280
Capital Lease Obligations	$1,575,499	$2,344,591	$3,016,964	$3,602,214
Total Capitalization	$-1,894,563	$-42,057,695	$-34,870,780	$-23,428,359
Additional Paid In Capital	$67,142,046	$1,032,125	$928,560	$541,872
Capital Stock	$3,176,688	$1	$904	$897
Common Stock	$242	$1	$904	$897
Preferred Stock	$3,176,446	$0	-	-
Long Term Capital Lease Obligation	$699,107	$1,575,499	$2,344,590	$3,016,964
Current Capital Lease Obligation	$876,392	$769,092	$672,374	$585,250
Pensionand Other Post Retirement Benefit Plans Current	$244,302	$68,697	$19,758	$764,303
Current Accrued Expenses	$1,590,425	$75,936	$80,636	$28,776
Net PPE	$1,992,888	$3,156,267	$4,273,465	$4,652,043
Accumulated Depreciation	$-2,026,070	$-1,587,889	$-1,127,167	$-650,892
Gross PPE	$4,018,958	$4,744,156	$5,400,632	$5,302,935
Other Properties	$3,972,206	$4,697,404	$5,353,880	$5,276,238
Machinery Furniture Equipment	$46,752	$46,752	$46,752	$26,697
Buildings And Improvements	-	-	$2,846,041	$3,442,575
Properties	-	-	$0	$0

Fetched: 2026-02-02

Cash Flow Statement (Annual)

Metric	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow
Free Cash Flow	$-5,789,987	$-12,403,543	$-10,706,946
Operating Activities
Operating Cash Flow	$-5,789,987	$-11,709,311	$-10,094,380
Cash Flow From Continuing Operating Activities	$-5,789,987	$-11,709,311	$-10,094,380
Operating Gains Losses	$-290,264	$-36,992	$-980,308
Investing Activities
Capital Expenditure	-	$-694,232	$-612,566
Investing Cash Flow	-	$-694,232	$-612,566
Cash Flow From Continuing Investing Activities	-	$-694,232	$-612,566
Financing Activities
Issuance Of Capital Stock	$0	-	-
Financing Cash Flow	$571,678	$5,625	$60,255
Cash Flow From Continuing Financing Activities	$571,678	$5,625	$60,255
Net Other Financing Charges	$-39,318	-	-
Net Preferred Stock Issuance	$0	-	-
Preferred Stock Issuance	$0	-	-
Other
Issuance Of Debt	$605,230	-	-
End Cash Position	$1,601,255	$6,819,564	$19,217,482
Beginning Cash Position	$6,819,564	$19,217,482	$29,864,173
Changes In Cash	$-5,218,309	$-12,397,918	$-10,646,691
Proceeds From Stock Option Exercised	$5,766	$5,625	$60,255
Net Issuance Payments Of Debt	$605,230	-	-
Net Short Term Debt Issuance	$0	-	-
Short Term Debt Issuance	$0	-	-
Net Long Term Debt Issuance	$605,230	-	-
Long Term Debt Issuance	$605,230	-	-
Change In Working Capital	$540,105	$-1,297,082	$492,340
Change In Other Current Liabilities	$-672,373	$-585,250	$-294,650
Change In Payables And Accrued Expense	$1,324,799	$-761,419	$689,264
Change In Accrued Expense	$44,239	$-692,685	$477,090
Change In Payable	$1,280,560	$-68,734	$212,174
Change In Account Payable	$1,280,560	$-68,734	$212,174
Change In Prepaid Assets	$-112,321	$49,587	$97,726
Other Non Cash Items	$35,655	-	-
Stock Based Compensation	$96,896	$381,070	$287,735
Depreciation Amortization Depletion	$1,117,198	$1,072,809	$735,473
Depreciation And Amortization	$1,117,198	$1,072,809	$735,473
Depreciation	$1,117,198	$1,072,809	$735,473
Gain Loss On Investment Securities	$-290,264	$-36,992	$-980,308
Net Income From Continuing Operations	$-7,289,577	$-11,829,116	$-10,629,620
Net PPE Purchase And Sale	-	$-694,232	$-612,566
Purchase Of PPE	-	$-694,232	$-612,566

Fetched: 2026-02-02